"Subcutaneous Omacetaxine Mepesuccinate in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) Resistant/Intolerant to Two or Three Approved Tyrosine Kinase Inhibitors (TKIs)(1)(")

Although people generally talk about "cancer", it is clear that the disease occurs in a bewildering variety of forms.

MISSISSAUGA, Ontario, April 24, 2012 /PRNewswire/ -- Kai Goulbourne is only eleven years old, but his life could be cut short if a matching bone marrow donor is not found soon. He

WASHINGTON, April 9, 2012 /PRNewswire-USNewswire/ -- A novel anti-leukemia compound with little toxicity successfully treated zebrafish with T-cell acute lymphoblastic leukemia (T-ALL), suggesting

Researchers reporting in the April Cell Stem Cell, a Cell Press publication, have found a way to stop leukemia stem cells in their tracks.